Suchergebnisse - "SUBKLEWE MARION"

PubPharm (17)

1

Recognizing, defining, and managing CAR-T hematologic toxicities

enthalten in: Hematology. American Society of Hematology. Education Program | 2023

von Rejeski, K. | Subklewe, M. | Locke, F.

2

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

enthalten in: Blood advances | 2023

von Blumenberg, V. | Busch, G. | Baumann, S. | +24

3

Mechanisms and strategies for safe chimeric antigen receptor T-cell activity control

enthalten in: International journal of cancer | 2023

von Stock, S. | Klüver, A. | Fertig, L. | +4

4

CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

ErratumIn: Cancer Immunol Immunother. 2023 May 8;:. - PMID 37154851

5

Reader Response : Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Neurology | 2023

von Karschnia, P. | Rejeski, K. | Subklewe, M. | +1

CommentOn: Neurology. 2022 Sep 20;99(12):511-515. - PMID 35851255

6

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer

enthalten in: Oncoimmunology | 2023

von Xu, T. | Karschnia, P. | Cadilha, B. | +22

7

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

enthalten in: Blood | 2022

von Rejeski, K. | Wu, Z. | Blumenberg, V. | +11

8

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies

enthalten in: Haematologica | 2022

von Dos Santos, D. | Rejeski, K. | Winkelmann, M. | +10

9

Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells

enthalten in: Neurology | 2022

von Karschnia, P. | Rejeski, K. | Winkelmann, M. | +10

10

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

enthalten in: Blood | 2021

von Augsberger, C. | Hänel, G. | Xu, W. | +33

CommentIn: Blood. 2021 Dec 23;138(25):2598-2599. - PMID 34940819